Our molecular tests combine clinical algorithms and artificial intelligence to provide advanced patient risk assessment to predict disease onset. GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. Our products help inform patients of their health risk enabling them to make behavioural or ‘lifestyle’ changes whilst providing doctors with greater genetic insight and clinical information to determine the most effective treatment pathway (precision medicine). GENinCode products combine genetic and clinical data to risk assess patients and provide healthcare practitioners with advanced clinical information to evaluate and predict the onset of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide. GENinCode specializes in cardiovascular disease risk.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |